Skip to main content
. 2016 Jun 30;3(5-6):164–172. doi: 10.18632/oncoscience.307

Table 1. Histopathologic and Molecular Characteristics of 24 Patients with Amplifications in FGFR/FGF signaling.

Case No. Histology ER status PR status HER2 status Biopsy Location Molecular Profile
1 Ductal Positive Positive Negative Liver ATM mutation R189K, AURKA amplification, CCND1 amplification, FGF19 amplification, ZNF703 amplification
2 Ductal Positive Positive Negative Breast PIK3CA mutation H1047R, CCND1 amplification, MCL1 amplification, EMSY amplification, FGF19 amplification, FGF3 amplification, FGF4 amplification
3 Metaplastic Negative Negative Negative Breast PIK3CA amplification, PTEN deletion, FGFR2 amplification, MYC amplification, TP53 mutation R273C
4 Ductal Negative Negative Negative Chest wall FGFR2 amplification, TP53 mutation R306*, CDH1 mutation Q264*
5 Ductal Positive Positive Negative Lymph node AKT1 mutation E17K, KIT amplification, FGFR1 amplification, MYC amplification, TP53 mutation P36fs*7, NFKBIA amplification, BCL2L2 amplification, ZNF703 amplification
6 Ductal Positive Positive Negative Metastasis PIK3CA mutation H1047R, PIK3R1 mutation G376R, CCND1 amplification, FGFR1 amplification, MYC amplification, MCL1 amplification, FBXW7 mutation D112E
7 Ductal Negative Negative Negative Liver FGF14 amplification, GATA3 mutation A333fs*20, IRS2 amplification
8 Ductal Negative Negative Negative Breast TSC2 mutation G1055fs*113, FGFR1 amplification, ATM mutation V1569fs*29, MCL1 amplification, TP53 mutation L111fs*40, MYC amplification, MYST3 amplification
9 Ductal Negative Negative Negative Breast CDKN2A mutation Y44fs*1, TP53 mutation, CCND1 amplification, CCND2 amplification, FGF19 amplification, FGF3 amplification, FGF4 amplification, FGF6 amplification
10 Ductal Negative Negative Negative Breast PTEN deletion, FGFR1 amplification, CCNE1 amplification, MCL1 amplification, MYC amplification, TP53 mutation Y234*, BCL2L2 amplification, NPM1 truncation 5′UTR, FAM123B mutation G303D
11 Ductal Positive Positive Negative Metastasis CCND1 amplification, FGFR1 amplification, PRKDC rearrangement, PTEN protein loss
12 Ductal Negative Negative Negative Breast FGFR1 amplificaiton, FGFR2 amplification, CCND1 amplification, MAP2K2 amplification, MYC amplification, TP53 mutation C242fs*5, PTEN protein loss
13 Ductal Positive Positive Negative Breast CCND1 amplification, FGFR1 amplification, ARID1A mutation Q708*
14 Metaplastic Negative Negative Negative Breast PIK3R1 mutation Y580fs*19, CCND2 amplification, CDKN2A deletion, FGF23 amplification
15 Ductal Positive Negative Negative Liver PIK3CA mutation E454K, BRCA2 mutation K3326*, CCND1 amplification, HRAS mutation G12D, GATA3 mutation D336fs*17, FGF19 amplification, FGF3 amplification, FGF4 amplification, MYST3 amplification
16 Ductal Positive Positive Negative Breast PTEN mutation E7fs*9, BRCA2 mutation K3326*, CCND1 amplification, EP300 mutation P925T, FGF19 amplification, FGF3 amplification, FGF4 amplification
17 Ductal Positive Positive Negative Breast ERBB4 amplification, HGF amplification, RICTOR amplification BCL2L2 amplification, JUN amplification, FGF10 amplification
18 Ductal Positive Negative Negative Abdomen FGFR3 amplification, PIK3CA mutation H1047L, CCND1 amplification, TP53 mutation R249M
19 Papillary Negative negative Negative Lymph node TP53 mutation S313fs*34, CCND1 amplification, FGF19 amplification, FGF3 amplification, FGF4 amplification
20 Ductal Positive Negative Negative Liver PIK3CA mutation E542K, CCND1 amplification, MCL1 amplification, FGF19 amplification, FGF3 amplification, FGF4 amplification, GATA3 mutation I362fs*49+, MAP2K4 mutation E299*
21 Ductal Positive Not Known Negative Breast PIK3CA mutation E545K, PIK3CA mutation Q546H, ATM mutation R2832C, CCND1 amplification, ARID1A mutation R1528*, FGF19 amplification, FGF3 amplification, FGF4 amplification
22 Ductal Positive Negative Negative Breast PTEN loss, KRAS amplification, MYC amplification, CCND2 amplification, TP53 mutation V272M, RB1 loss, FGF23 amplification, FGF6 amplification, KDM5A amplification
23 Ductal Positive Positive Negative Breast PTEN splice 1087_1088ins47+, TSC2 mutation N363fs*29, FGFR1 amplification, CCND1 amplification, MDM2 amplification, MYC amplification, TP53 mutation P278T, MDM4 amplification, FGF19 amplification, FGF3 amplification, FGF4 amplification, MYST3 amplification, ZNF703 amplification
24 Ductal Positive Negative Negative Breast CCND1 amplification, Ep300 mutation P925T, FGF19 amplification, FGF4 amplification
HHS Vulnerability Disclosure